Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label in the page footer updated from v3.6.5 to v3.6.6. This appears to be a site-version bump and does not alter the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-09-01T20:32:00.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update. No substantive study information or visible content changes occurred.
    Difference
    0.1%
    Check dated 2026-08-11T17:07:35.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor deployment update to the page. No study data or content changes are reflected in this update.
    Difference
    0.1%
    Check dated 2026-07-28T10:10:28.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    An update to the page revision from v3.6.2 to v3.6.3 was applied, signaling a new version of the page. This change records a version bump rather than a modification to the trial content.
    Difference
    0.1%
    Check dated 2026-07-07T02:40:11.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This indicates a platform or content update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:44:59.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment status as No longer looking for participants. The Intervention/Treatment label is standardized (replacing Intervention / Treatment) and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:36:53.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.